Suddenly the hottest thing in biopharma isn’t a new indication, disease target or modality—it’s manufacturing, and all of ...

The world of supply chain fulfillment is being driven by workforce shortages, minimum wage increases and the relentless push ...

The majority of Teva's business lies in generic and off-patent branded drugs and faces price and volume pressures that will be exacerbated as regulatory actions and other players in the drug supply ...

In this edition of Data Spotlight, we explore how investors can use AI to extract insights from news feeds and analyze supply ...

Biocodex is a French, family-owned, pharmaceutical company that has grown from microbiota pioneer to an international leader with its diverse portfolio focused on three areas of expertise: microbiota ...

While Indian pharma companies could gain a competitive edge in the US market, the move may disrupt the medical device supply ...

Report on how AI is redefining market landscape - The healthcare logistics market in canada size is estimated to grow by USD ...

Creating contingency plans against geopolitical uncertainty was a key theme at the 2024 Outsourcing in Clinical Trials and ...

Bachem's Pascal Degen explains the challenges faced by CDMOs in a volatile, uncertain, complex and ambiguous (VUCA) world.

The pharmaceutical industry faces significant challenges with supply chain waste, affecting both environmental sustainability ...

The pharmaceutical ... to invest in the industry by providing both fiscal and non-fiscal incentives. The government also supports local manufacturing and improves supply chains by adopting digital ...